INTELLIGENCE

FTC Orphan Drug Pricing Investigations: What You Should Know

Amanda Hamilton recently had her article “What Can the FTC Do about Orphan Drug Prices?” published in the Antitrust Health Care Chronicle for August 2017.  Her article analyzes what the FTC looks for when investigating orphan pharmaceutical price claims.

Read the article here.

SHARE

PRINT THIS PAGE

RECEIVE EMAIL UPDATES

Name(Required)